|
Re-sending of this newsletter to any number of colleagues is encouraged provided you also cc: report@medsuds.com. In return, we will invite recipients to subscribe. Any other unauthorized re-distribution is a violation of copyright law. Subscribe to the MedSuds Report at http://www.netsuds.net/mail.htm. You can get the web versions of these reports at http://www.medsuds.com/report/. In this Issue: 1.0 Heard on the Net 1.0 People And Companies On The Move: CLICK HERE FOR PEOPLE AND COMPANIES ON THE MOVE In the past, we've published information about people and companies on the move in our monthly report. Now you can publish and view that information instantly on our web log (blog)! To view, click on http://medicalsudsannounce.blogspot.com/. You can report a change in your job status if you are moving from or to a company in the medtech, biotech or life sciences markets. Include your new work contact information, not just your personal contact information. If you don't want to use the BLOG, send me an email at onthemove@medsuds.com. I'll publish the information for you. If you are with a 'company on the move', email onthemove@medsuds.com to report (1) the formation of a new start-up, (2) momentum change at an existing start-up, (3) addition of key hires, or (4) a funding event at a start-up. We do not accept press releases from third parties. We must hear directly from a company that is ‘on the move’. You can include a 80 x 100 pixel (width x height) photo in JPG or GIF format. Why email only to your small email list of associates when you can post this information on the blog and have 2500+ MedSudsers view it. To publish to the blog send me an email requesting permission. After you have an account, you can post to the blog as much as you want. You need only follow some common sense guidelines, e.g. don't post every press release, don't post sales information, don't post defamatory statements, etc. If you "spam" the blog, you will be removed. 2.0 Jobs in the "medtech, biotech and life sciences" Market Please email: matt@medsuds.com to report job openings in the medtech, biotech and life sciences market. In the body of the message, provide the name of the company and a URL link to the job postings.
3.0 Schedule of Events You can also try our online calendar by clicking here for NetSuds and here for MedSuds. The web calendars for NetSuds and MedSuds continue to grow in popularity as more and more people use them for the definitive place to find high-tech events in the Twin Cities. The calendars are free to use for both tracking events and for posting your own events. To post events, login as "guest" with a password of "guest". The Calendars are accessed at
NetSuds -
http://www.netsuds.net/cgi-bin/calweb/calweb.pl?cal=default Non-Minnesota companies conducting events in Minnesota will not be allowed to post events for free. Events posted to either of these calendars are not immediately available for viewing. All events will be marked "pending" and will be reviewed for content prior to public viewing.
4.0 Tidbits
MedSuds welcomes tours of
your facility! Email us if you want to show off your company. Contact
Janet Rebman Lillevold at
janet@medsuds.com.
4.1.1 LumiLife
by
MedSuds Editor Janet
Rebman Lillevold, 952.249.8254,
janet@medsuds.com Packaging problem? Require a quick turn around for a
customer or clinical trial? Turning your packaging department on its head
to package a product that doesn’t lend itself to easy automation or
robotics, or isn’t in your current core competencies for packaging?
LumiLife is a medical manufacturing facility in Bloomington, MN that focuses
on delivering solutions to these and other similar problems. Started in 1996 by Samnang Chan and his family,
LumiLife is an assembly and packaging provider with capabilities for class
10 to 10,000 environments. Services include: ultrasonic cleaning and
passivation, contract sterilization, lab testing, validation, assembly and
packaging, GMP compliance, and full traceability. LumiLife is an
FDA-registered facility and is ISO 9001:2000 certified. According to John Dykstra, Business Development
Manager, LumiLife is centered on being a service organization to the medical
device industry, actively partnering with companies that need or want to
outsource their packaging due to capacity, capability, or scheduling
issues. “With our abilities to handle from low to high volume capacities
and to package those difficult to automate products, we can provide services
to companies ranging from start-ups that lack production capacity to large
companies engaged in trial projects.” LumiLife has assembly and packaging experience with:
spinal implants, dental implants, orthopedic products, neurological and
surgical kits, syringe assemblies, urinary incontinence devices, electronic
component assembly, and disposable sterile and non-sterile devices.
LumiLife also offers services in: package design, process validation,
in-process and final inspection, turn-key sourcing and inventorying of
materials, and vacuum sealing and nitrogen purge packaging. For additional information on LumiLife (www.lumilife.com)
or to visit the facility, contact John Dykstra, Business Development
Manager, at 952-888-6687, ext. 303. LumiLife is located at 809 West 106th
Street, Minneapolis. 4.2
Email Advertising
The
NetSuds
(5500+) and
MedSuds
(2500+)
email lists reach 8000+. The
NetSuds
email lists are double-opt-in and concentrated on professionals in the
communications, IT and Internet markets. The
MedSuds email lists are
double-opt-in and concentrated on professionals in the medtech, biotech and
life sciences markets. So, rather than spend your
advertising dollars on any other email lists in the Twin Cities, consider the
NetSuds and
MedSuds
lists. Contact
matt@medsuds.com or 612.605.5252. For current ad rates, visit
www.netsuds.com/adrates.htm. See the following URL for more information on our executive
search service -
www.medicalsuds.com/search/.
4.4
MedSuds
CEO Roundtable - Next Roundtables starting in June 2004
MedSuds
is opening up another group of CEO Roundtables in June 2004. If you are tech or medtech CEO and want to join us, (the
first session is free), contact
matt@medsuds.com. A synopsis of the CEO
Roundtable can be found at
www.medsuds.com/ceo/ It is repeated here
as well.
MedSuds
CEO Roundtable Membership Only CEOs of tech and
medtech companies are allowed to join the
MedSuds
CEO Roundtable. If you are a VP, CxO or President, you are not welcome
unless you also hold the CEO title.
If you are interested in becoming a member, contact
matt@medsuds.com.
Membership is not automatic. There must be an available spot open in the
roundtable. You must have employees. Your company must be
incorporated. Your company must be a tech (communications, IT,
software, Internet) or medtech (medtech, biotech, life sciences) company. You
must pay a yearly fee of $1200 in advance. You may not send substitutes to the
Roundtable. Roles Unlike the days of knights,
kings and Camelot, there is no king of the
MedSuds
CEO Roundtable; only a facilitator; Matt Noah, CEO of NetSuds.com, Inc.
Knights are replaced by CEOs and the table won't be quite round. Schedule The Roundtable will meet at least 10
times per calendar year. We meet the last
Tuesday of every month. Each meeting lasts between 2 hours starting at 7 am. A facility
convenient to the majority of Roundtable members is used. A continental breakfast
is served. Purpose CEOs need resources to
assist them in executing their duties and leading their companies. Boards
of Directors and upper management are not always the best or most independent
resources upon which to draw. The CEO Roundtable exists to provide CEOs
with an independent resource of wisdom and shared experience. Your key
'take-aways' from the Roundtable will be accelerated learning - so as to avoid
common and uncommon pitfalls -, an expanded network of advisors and colleagues
and tools to enhance the productivity and value of your enterprise. Content First, networking among the
CEO members of a Roundtable is the best and richest content. Second, the
Roundtable facilitator will schedule subject matter experts of interest to the
CEOs. Examples include intellectual property, branding, sales,
engineering, marketing, finance, compensation, human resources, M&A, etc. Format Meetings consist
primarily of 2 elements. First, "content" will be presented and discussed.
Second, "discussion" of common problems and solutions will take place. The
facilitator will lead both elements or assign elements to certain CEOs. Confidentiality Roundtable meetings
are completely confidential. Nothing said in a roundtable discussion,
short of illegal activity, leaves the meeting. This allows each CEO to
feel comfortable discussing issues and subjects he may not feel comfortable
speaking about with others. 4.5 Citizen's Council on Health Care "Government Should Not Direct the Practice of Medicine," Say Panel of MN
Physicians and Business Owners (St. Paul, Minnesota) - To counter the support of the Minnesota Medical
Association and the Minnesota Chamber of Commerce for "best practices"
health care legislation, Citizens' Council on Health Care (CCHC) brought
together a panel of 4 physicians and 3 business owners today to discuss the
issue with the news media: - Dr. Paul Bearmon, MD - Mel Brandl, owner, Printmaster - Dr. Steve Brzica, MD - Dr. Dale Hammerschmidt, MD - Dr. Spencer Johnson, MD - Harold Hamilton, owner, Micro Control Company - William Wenmark, owner, Now Care Medical Centers "Government Will Tell Doctors How to Practice Medicine" was the heading
of a large display board that listed and described government actions
authorized by the House and Senate Health and Human Services Omnibus bills,
HF 1681 and SF 1760: - Impose Bias - Collaborate with HMOs - Practice Medicine - Violate Privacy - Coerce Doctors - Control Doctors - Penalize Non-Compliance "If the proposed legislation becomes law, state government will be
empowered to direct patient care-quite simply, to, disease by disease, tell
your doctors how to practice medicine," said Twila Brase, president of CCHC.
"The doctor-patient relationship will be done. The doctor-bureaucrat
relationship will begin," said Dr. Steve Brzica, MD, anesthesiologist at
Fairview Southdale Hospital. "If we're going to use a cookbook
approach, perhaps we should computerize the process and eliminate doctors,"
said Harold Hamilton, tongue-in-cheek. Hamilton, owner of Micro Control
Company, noted that individual doctors do better than bureaucracies in
determining what is best for patients. The Health and Human Services omnibus bills which contain the "best
practices" proposal have passed both the House and Senate and await
conference committee action. The Governor signaled his support for the
proposal in his State of the State address, saying his administration will
"force health care providers to use best practices." "This is a dangerous proposal, yet there has been virtually no public
debate about it. The public must be informed about this proposal before the
legislature requires their doctors to work for government first and patients
second," concluded Brase. Citizens' Council on Health Care is an independent, non-profit,
free-market health care policy organization located in St. Paul, Minnesota.
… by
MedSudsers
Gary Dion and
Susan Follett,
Co-Principals, SugarCubed, Inc., specializing in large-scale change management
to achieve product delivery performance. Services include due diligence, merger
integration, accelerating operational performance, and project recovery. Contact
the authors at 503.579.4735 or either
Gary.Dion@SugarC.com or
Susan.Follett@SugarC.com. M&A is a
central element of growth strategies for today’s companies who seek market
leadership. Despite the importance of M&A:
·
70 to 80% of
companies that make acquisitions are not satisfied with their outcomes.
·
Approximately 50%
of all acquisitions actually damage the original company.
·
Many turnarounds
become necessary when M&A goes bad. Frequently, these fail as well. What accounts
for this dismal success rate? There are a variety of possible contributing
factors, including lack of leadership, ineffective due diligence, lack of a plan
for merger integration, and failures of execution. To look at any one of these
alone, though, is to look at the problem much as the blind men who describe an
elephant from their various perspectives. Just as each
of the blind men is correct in his description of part of the elephant, each of
these contributing factors is part of the answer. Also, just as the blind men
individually fail to understand the elephant, achieving sane and successful
mergers and acquisitions requires a big-picture approach. An article in
the McKinsey Quarterly, 2001, issue 4, asserts that “A failure to focus
on revenue may explain why so many mergers don’t succeed.” Revenue is the
essential ingredient for growth, and growth is the overarching goal of most
acquisitions. What
does a revenue focus mean? Any focus on
revenue, whether in times of acquisition or not, must have at its core a focus
on product operations – the functional organizations that deliver the products
on which the company’s revenue is based. These organizations typically include:
product management, marketing, engineering/development, engineering services,
and customer services and support. Despite the
criticality of product operations, the focus of M&A is frequently skewed to
financial and legal considerations of the deal itself. The assumption is often
made that organization, process, technology, and culture integration can wait
until the transaction is complete. However, when due diligence and negotiation
are not based on a thorough understanding of product operations, results can be
disastrous. Furthermore,
merger integration is often limited to corporate systems and processes where
cost efficiencies are anticipated. Neglect of product operations at this stage
is counter-intuitive, considering that the vast majority of acquisitions are
initiated to achieve growth – by accelerating expansion of the product
portfolio, entering new markets, or increasing share and revenue from existing
markets. What
tools are required to support a revenue focus?
Revenue-focused mergers and acquisitions – those that achieve corporate growth –
require two things that organizations such as Intel Capital are beginning to
understand and adopt:
·
A well-managed
M&A life cycle process
·
A methodology
that ensures proper attention to product operations – the revenue-producing
engine of the company Experience has
taught such companies two key lessons: Those
companies who have yet to understand the importance of a well-managed M&A life
cycle process grounded in a methodology that ensures thorough inspection of
product operational capability will likely suffer repeated dissatisfaction with
acquisition outcomes. As John
Dryden, seventeenth-century English poet and dramatist, so eloquently put it,
“Insanity is doing the same thing over and over again and expecting different
results.” Dryden’s view applies no less to M&A. Still
not convinced? Still
skeptical? Do any of these describe your company’s M&A experience?
·
This isn’t our
first acquisition. But each time one comes up, we find ourselves scrambling to
pull together a due diligence team. And we never seem to catch up.
·
After the deal,
the “secrets” come out. That’s when we discover the real issues.
·
The acquired
company’s chief architect, who seemed like such a nice guy, is now stymieing the
effort to produce an integrated product portfolio.
·
Our cultures and
processes are so different. It’s been 18 months, and we still can’t work
together.
·
The product
architectures are incompatible, and we can’t agree on an approach to fix this.
·
On first
examination, the company we acquired looked really good. But they can’t deliver
to plan, and customer issues keep derailing us.
·
We keep shifting
our key people to the new organization. Now we’re putting our own delivery and
market commitments at risk. What
does a well-managed M&A life cycle process include? An efficient
and repeatable M&A life cycle process ensures requirements-based action and
criteria-based decision-making at key stages that should include: strategic
planning, candidate development, due diligence, integration planning,
negotiation, and integration. 1.
Strategic Planning Strategic
planning yields an acquisition strategy that includes business objectives,
requirements, and value drivers for an acquisition. This stage
allows for acquisition strategies to be developed within the context of the
company’s overall business planning process. The acquisition strategy should
support business vision and objectives and the growth and market strategy. Along
with strategies for internal product development and alliances/partnerships, the
acquisition strategy should be an integral component of the corporation’s
investment strategy. 2.
Candidate Development Driven by
the acquisition strategy, the candidate development stage identifies one or more
acquisitions to be pursued. Target
selection requires comparison of candidates in terms of expected ROI;
anticipated obstacles, complexities, issues, and risks; intangibles; and an
initial understanding of merger integration requirements. In this stage,
preliminary due diligence examines broad business, market, financial, and legal
considerations. For agreed upon targets, preliminary deal communications and
negotiations are conducted. 3. Due
Diligence Due
diligence seeks specific, comprehensive knowledge of the candidate’s business,
systems, people, processes and tools, products and technology, culture, markets,
customers, suppliers, and overall performance capability, for use in guiding
negotiation and integration. The focus of
due diligence should be uncovering issues, determining whether or not they are
deal killers, and, if not, developing a plan to address them during negotiations
and after deal completion. To assist, a gap analysis is performed to assess
“what is” against “what is needed.” Recommendations for deal decision-making,
terms, and corrective actions are provided to stakeholders and the negotiation
team. A
methodology for ensuring a thorough inspection of product operational capability
is an essential tool in the due diligence assessment process. (See “What does an
operational assessment and integration methodology offer?”) 4.
Integration Planning Guided by
the findings of due diligence, the integration planning stage yields a roadmap
for achieving the required post-integration business model and associated ROI. The
integration plan addresses all key performance areas, identifying corrective or
risk mitigation actions for each gap discovered during due diligence. A core
integration team is chartered to develop the plan and lead the integration. The
plan may be phased, based on business strategy and priorities, and should
include measures of progress, completion, and value. Buy-in from executive
management and major stakeholders is essential. 5.
Negotiation The
negotiation stage is based on information from strategic planning and due
diligence. Terms of the
deal must be defined so as to ensure that business and acquisition objectives,
requirements, and value drivers can be achieved. In doing so, priority must be
placed on the operational considerations (including people, organization,
process, tools, and culture) that are essential for successful integration and
ROI. 6.
Integration The
integration stage is managed by the core integration team chartered during
integration planning. As the
integration plan is executed, regular and consistent measurement of progress,
management of issues and risks, and information flow to executive management and
stakeholders are essential. Along the way, shifts in business, market, product,
or technological strategies may necessitate changes to the plan and must be
managed. A post-project review assesses success and identifies process
improvement recommendations. What
does an operational assessment and integration methodology offer? Although
problems are not entirely avoidable, the key is uncovering issues early and
developing a plan to address them. Therefore, the most successful mergers and
acquisitions are guided by a methodology that ensures a comprehensive and
thorough inspection of product operational capability. In our work
with companies such as Intel, we use a methodology that:
·
Prescribes a
process for preparing for and conducting due diligence and managing findings
during negotiation and integration
·
Includes a
generic set of performance indicators that can be tailored based on the nature
of the deal at hand The generic
performance indicators cover these high-level categories of product operations:
·
Business purpose
and market strategy
·
Product and
technology
·
Management,
leadership, and culture
·
Business
operation and organization structure
·
Personnel,
expertise, and functional capability
·
Product planning,
development, delivery, and support processes and practices The tailored
set of performance indicators is used to generate criteria that define exactly
what aspects of the candidate’s operation must be in place for a successful
integration and return on investment. These criteria drive interviewing,
investigation, and gap analysis during due diligence.
What’s the bottom line? The most
successful mergers and acquisitions are guided – from initial planning through
merger integration – by a well-managed life cycle process and a methodology that
ensure:
·
Comprehensive and
thorough inspection of all aspects of the product technology and operation to be
acquired and integrated
·
Decision-making
and execution based on an integration plan that directly supports business
strategy, objectives, and priorities
·
Early discovery
and management of operational and technological issues and risks In M&A, the
“invest now, or pay much more later on” principle is especially true. A sound
investment in life cycle and methodology ensures the least disruption to product
delivery and sales operations following the transaction. This attention to
revenue affords the greatest likelihood of efficiently and expeditiously
achieving desired ROI from acquisitions. It’s a formula for sanity and success
in M&A. 6.0
Medical
Content is (Still) King … by
MedSudser
J. N. Buchwald,
Director and CEO of Medwrite Medical Communications (www.medwritecomm.com),
a Mpls.-based agency serving device, diagnostics, healthcare, and
pharmaceutical businesses worldwide for nearly two decades.
Feel free to send comments to
jbuchwald@medwritecomm.com, or call 952-941-1660. Content is (Still) King © 2004 J.N. Buchwald.
Since the nineteenth
century, with the founding of peer-reviewed medical journals, physicians and
medical researchers have had an international forum for sharing their new
developments and for building on one another's progress. Yet, the medical
businesses that grew up around that research in the past century have been
challenged with the question of how to credibly deliver information to their
audiences in an increasingly regulated healthcare arena.
Despite the almost
irresistible impetus to apply the newer media—the internet, interactive
multimedia, DVDs, and more—medical organizations must ponder not only which
kind but in what instances to insert that media, and how to do so cost
effectively. It is sometimes difficult to remember that even in this high-tech
communications era, substantive, well-developed, researched content that
clarifies medical ideas for a specific audience remains the
commodity critical to the successful introduction, sale, and
implementation of every medical product. All of the "shockwaves" and streaming
video in a webmaster's arsenal cannot disguise inadequately researched,
incompletely conceived, poorly written medical content.
Content is the product
The FDA is the primary
market driver of the contemporary U.S. medical industry, closely followed by
the peer-review publishing system that oversees the flow of journal content
that essentially “legislates” today’s evidence-driven medicine. Product
marketing materials follow on the heels of the investigative and clinical
literature, which must be interpreted accurately and published appropriately
to be viable long term. Questions of copyright, and what constitutes
educational versus promotional material must be answered in the process of
developing informational, marketing, and training programs.
Choosing secondary media
After the presentation of
trial results via academic publications, businesses must implement
communications programs of all kinds to delineate those data and promote
products whose success depends upon them. Choosing new media to accomplish
this job is not always the most effective strategy. Sometimes the very
novelty or complexity of a new medium undermines its usefulness. Traditional
articles, white papers, slides, training binders, video, audiotapes and demos
are still unbeatable tools for a pre-qualified, receptive audience.
Nonetheless, in today's fast-paced medical industry, the cost-to-value of
creating a web portal or interactive laptop CD-ROM is, in some settings,
superior to that of funding traditional media for reasons directly related to
the centrality of content visibility in the medical environment.
Once a premium is placed on
expert knowledge assembly, the fit of a variety of high-tech communications
delivery vehicles can be considered.
Portals
onto worlds
After a basic “medweb”
(website) has established a company’s presence, portals may be excellent
corollary windows onto an array of compiled and real-time educational
opportunities. Smartly built portals are readily navigable, ushering viewers
through richly layered, topic-specific content on disease states, medical
procedures, technology, drug-choice algorithms, etc. while providing links to
other relevant sites.
Portals (e.g.,
www.WebMD.com and
www.healthstream.com) can provide credible avenues for disseminating
continuing medical education (CME) while providing subtle, logical sponsorship
opportunities, including syndication of the portal to facilitate its regional
customization. Portals can be developed in concert with strategic partners to
offer product and indication information on a revenue-sharing basis as a free,
value-added service to target audiences (physicians, patients, healthcare
professionals).
Show and tell
multimedia
A single CD-ROM can store
and present a tremendous amount of localized textual content combined with
engaging visuals: audio that reaches out with the warmth of a narrator's
voice; live echocardiographic images or video of physicians speaking or
performing surgery; patients sharing firsthand experience; and illustrations
and animations describing device or drug modes of action. Communicating with
audiences through CD-ROM can facilitate interactivity with field reps and
customers via uplinks to websites where evaluations may be performed, patient
or research information can be logged to a database, and many other
interactive tasks administered.
Medical businesses now may
save millions of dollars on trainers, training material, flights and
accommodations for the field force by mailing them CD-ROMs loaded with all of
the information necessary for their own training and for presentations when
calling on physicians—CD-ROM product demos can be launched by sales reps from
a physician's desktop computer or from rep laptops.
Don't
work without an intranet
Internet applications
available only to employees and affiliates through password-protected access
provide a place to quickly obtain shared company knowledge or perform
efficient, cost-effective training. New modules can be placed online at any
time at minimal cost. Today, intranets serve as virtual libraries for
organizations—expressions of the collective learning, or braintrust, of a
group.
Heavy lifting can be taken
out of research by expanding an intranet to present targeted case studies or
abstracts from the most recent peer-reviewed publications for interested
physicians, nurses, or a busy sales force which cannot always keep up with the
newest literature. A hired medical communications firm can research and
develop original abstracts to conserve your company’s staff resources while
keeping internal company knowledge workers and mobile audiences abreast of all
new research during the full product lifecycle.
Garner wide readership with e-zines
Electronic magazines (e-zines, online versions of medical
journals/periodicals) or original publications developed and administered by
independent communications publishers via unrestricted educational grants
provide the option of paperless reading and downloadable issues. Well-promoted
e-zines can reach highly targeted or vast international audiences, and can be
funded through advertisement and subscription. E-zines may also be sponsored
as a service to customers, keeping them close enough to share news with
electronically on a regular basis.
Make the old new
Sometimes using a traditional, but untapped, medium provides a new cutting
edge. Increasingly, device and diagnostics product managers and publications
coordinators borrow a time-honored pharmaceutical industry tool—journal
supplement sponsorship. In doing so, they gain the credibility conferred only
by independent publication and by employment of the peer-review process; they
garner the opportunity to speak directly to a well-known journal's
circulation, and to share disease-state expertise while their products move
through preclinical and clinical development. Though not new media,
sponsored supplements and monographs garner new audiences and deepen
product visibility with the highest level of credibility short of journal
articles. Caveat emptor
Experienced in-house medical writers and medical communications professionals
are responsible for helping businesses maintain the ground rules of FDA
regulation and peer-review publication while selecting and developing the
media that best showcase their products. When contracting with a medical
communications firm, be wary of those that would be all things to all
customers. Look for an agency that is not first and foremost versed in
advertising or IT; seek a dedicated medical communications agency with direct
knowledge of med/pharma, FDA regulation, and medical education accreditation.
Worth your time and budget
The
medical communications partner you seek to support core knowledge assembly
objectives and develop key communications programs should offer verifiable
data demonstrating ROI, and the following: •
Credentialed, experienced medical writers, editors, illustrators, and new
media producers; • An
inspiring capabilities presentation that unambiguously demonstrates
best-in-class publications, deep experience, and a large body of work,
preferably executed for both local and international medical organizations;
• Accreditation/affiliation
to produce CME;
• Medical research
expertise through bricks-and-mortar and online biomedical libraries; •
Working partnerships with IT companies that build hardware and software
systems that support searchable, updatable content; •
Industry-appropriate rates and proven production schedules; •
Available customer references, a list of significant previous customers,
preferably a strong record of repeat business; and •
Professional association affiliations and relationships with educational
institutions.
Technology alone does not
constitute value added. High-quality content married to the appropriate media
secures competitive advantage every time. 7.0 Inlet
Medical Inc. – Charting their Future in Women’s Health by
MedSuds Editor Janet
Rebman Lillevold, 952.249.8254,
janet@medsuds.com
“The women’s health industry is a gold mine waiting to happen” according to
Lee Jones, President and Chief Executive Officer of Inlet Medical, Inc.
“The key to winning in women’s health (for Inlet) is to determine a way so that
every time a physician touches a patient, he or she uses an Inlet product”. Founded in 1992 and then refocused in 1997, Inlet Medical is a privately held
medical device company that offers branded procedure-based solutions in the
women’s pelvic health market. Inlet’s strategy is to develop products and
procedures that: meet unmet medical needs; treat a variety of conditions that
affect women through the continuum of life stages; offer benefits to doctors,
hospitals, and patients; are easy to use; and leverage Inlet’s core
technologies. Inlet Medical’s current product line consists of laparoscopic surgical
products and procedures for: uterine prolapse repair, uterosacral support
after hysterectomy, facilitation of uterine suspension, and facilitation of
full-thickness trocar wound closure. Other applications for the products
include litigation of abdominal wall bleeders and tacking of hernia mesh prior
to final placement. To drive interest and exposure to their products, Inlet uses a two-pronged
approach, targeting both the physician and the patient (consumer) through two
distinct websites (inletmedical.com and inletmedical.org). The primary audience
for driving Inlet Medical’s business is the physician, but by also informing the
patient, Inlet is using a strategic, consumer-focused education process to
indirectly create demand and generate market turns. Through the consumer web
site, consumers can learn about their health issues, understand potential
solutions, and through the Patient Connection Program, they can request contact
information for physicians in their area who understand their health problems
and offer them options. According to Jones, the offering of options is the key
message that Inlet is communicating to target physicians. Unlike the past,
today’s female health consumers are not satisfied with a single, set diagnosis
from their physician; they expect and demand alternatives. And if they don’t
receive alternatives; they will go elsewhere. Currently, Inlet Medical’s consumer website receives 86,000 visitors (39,000
unique visitors) per month with an average of 5329 pages viewed per day. Their
medical professional site receives 7489 visitors (4813 unique visitors) per
month with an average of 414 pages viewed per day. The medical professional
site includes procedure and kit descriptions, clinical study results, case
studies, physician training and support, presentations, and other professional
information. With only two months left in their fiscal year, Inlet Medical is solidly
on the road to their first year of profitability and Jones contributes this
success to hard work and to their outsourcing business model. Using the
approach that a company must hire the best expertise available, but
acknowledging that cash flow is a restriction, Inlet obtains a significant share
of their talent on a consulting or project basis. What does Inlet Medical outsource? Their product manufacturing, office
operations, product promotion and marketing, and sales (sales representatives
and web-based training). What do they own? Their marketing, sales (telephone
sales, management, training, and customer service), and products. Why does this
approach work? According to Jones, “it works because outsourcing reduces
overhead and cost. You purchase the top talent only when you need it and
outsourcing reduces barriers to action within the company.” Inlet Medical has found that not only do they have a streamlined development
to launch process with outsourcing, but that you can measure and feel the
positive impact of outsourcing savings very quickly. For example, when Inlet
Medical outsourced their credit collection, they went from 60 to 30 days for
outstanding receivables. This decrease in outstanding receivables allowed
Inlet Medical to remove one entire month of debt and positively changed their
credit view from a banking perspective. Inlet Medical’s business model also works because they retain close control
of critical functions such as customer service, listening and learning from the
physicians and consumers, and then driving their product development and
marketing messages appropriately. With a continuing, solid sales growth trend, where does Inlet Medical go from
here? Forward in their creation of new and improved solutions for women’s
health. To obtain additional information on Inlet Medical, Inc., contact Lee
Jones at 952-942-5034. Inlet Medical, Inc. is located at 10340 Viking Drive,
Suite 125, Eden Prairie, MN 55344. 8.0 Guest Writers for This Report The
MedSuds Monthly Report
welcomes guest writers! If you have a passion for a topic, and you can write,
send an email to
janet@medsuds.com or
matt@medsuds.com. You can even send
copies of your work. It needs to be on med-tech, biotech or life sciences topics
and can include entrepreneur/investor activities. Good information from our
service providers and vendors is also welcome so long as it is not a
"commercial" for any one company or individual. We will consider any qualified columnists
and guest writers. If you are aware of others who would like to receive the
MedSuds Report, ask
them to visit
http://www.netsuds.net/mail.htm
to subscribe or
unsubscribe. |